Clinical Significance of Quantitative HBsAg Titres and its Correlation With HBV DNA Levels in the Natural History of Hepatitis B Virus Infection.

[1]  Liang Yu,et al.  Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study. , 2014, World journal of gastroenterology.

[2]  M. Maini,et al.  NK Cells: A Double-Edged Sword in Chronic Hepatitis B Virus Infection , 2013, Front. Immunol..

[3]  F. Antaki,et al.  HBsAg titers in the different phases of hepatitis B infection in Syrian patients. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  P. Marcellin,et al.  Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report. , 2011, Journal of hepatology.

[5]  M. Choi,et al.  The change of the quantitative HBsAg level during the natural course of chronic hepatitis B , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[6]  V. Wong,et al.  A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B , 2010, Hepatology.

[7]  S. Locarnini,et al.  Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. , 2010, Journal of hepatology.

[8]  M. Manns,et al.  Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. , 2010, Journal of hepatology.

[9]  S. Locarnini,et al.  The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B , 2009, Hepatology international.

[10]  P. André,et al.  Clearance of serum HBsAg and anti‐HBs seroconversion following antiviral therapy for chronic hepatitis B , 2009, Journal of medical virology.

[11]  H. Wedemeyer,et al.  17 KINETICS OF HBsAg DECLINE IN HBeAg+ CHRONIC HEPATITIS B PATIENTS WITH 3 YEARS OF TELBIVUDINE TREATMENT DURING THE GLOBE STUDY , 2009 .

[12]  P. Marcellin,et al.  Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B , 2009, Hepatology.

[13]  T. Asselah,et al.  Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa‐2a in HBeAg‐negative patients , 2009, Hepatology.

[14]  R. Binda,et al.  Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus , 2009, Immunology.

[15]  Jianming Hu,et al.  Hepatitis B virus–cell interactions and pathogenesis , 2008, Journal of cellular physiology.

[16]  G. Fattovich,et al.  Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. , 2008, Journal of hepatology.

[17]  S. Locarnini,et al.  The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus-host relationship based on molecular virology and immunopathogenesis considerations? , 2007, Gastroenterology.

[18]  Olga Angelopoulou,et al.  Prediction of Treatment-Related HBsAg Loss in HBeAg-Negative Chronic Hepatitis B: A Clue from Serum HBsAg Levels , 2007, Antiviral therapy.

[19]  B. Das,et al.  Hepatitis B virus genotypes in chronic liver disease patients from New Delhi, India. , 2006, World journal of gastroenterology.

[20]  C. Galli,et al.  Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  Sheng-Nan Lu,et al.  Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers , 2004, European journal of gastroenterology & hepatology.

[22]  Yoshinori Iwatani,et al.  Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. , 2004, Journal of virological methods.

[23]  B. McMahon,et al.  The Natural History of Chronic Hepatitis B Virus Infection , 2004, Seminars in liver disease.

[24]  D. Vassilopoulos,et al.  Hepatitis B e antigen–negative chronic hepatitis B , 2001, Hepatology.

[25]  A. Sutnick,et al.  Hepatitis and leukemia: their relation to Australia antigen. , 1968, Bulletin of the New York Academy of Medicine.